Used in research settings to detect and quantify antibodies against adeno-associated viruses (AAV) in mouse serum or plasma samples. Helps assess immune responses in preclinical gene therapy studies where AAV vectors are used as delivery tools. Enables researchers to monitor the development of anti-AAV antibodies, which can impact the efficacy and safety of gene therapies. Supports optimization of vector design and dosing regimens by providing insights into host immunogenicity. Commonly applied in pharmaceutical and academic laboratories during the development and evaluation of AAV-based therapeutics.